Table 1 Clinical scores used to evaluate variables before and after treatment
From: Use of miltefosine to treat canine visceral leishmaniasis caused by Leishmania infantum in Brazil
| Clinical signs | Intensity (scores) | |||
|---|---|---|---|---|
| 0 | 1 | 2 | 3 | |
| Anorexia | A | P | ||
| Polyuria/polydipsia | A | P | ||
| Epistaxis | A | P | ||
| Splenomegaly | A | P | ||
| Vomiting | A | P | ||
| Digestive disorders | A | P | ||
| Uveitis | A | P | ||
| Keratitis | A | P | ||
| Arthritis/limping | A | P | ||
| Onychogryphosis | A | M | I | |
| Weight loss | A | M | I | |
| Conjunctivitis | A | M | I | S |
| Blepharitis | A | M | I | S |
| Lymphadenomegaly | A | M | I | S |
| Ulcers | A | M | I | S |
| Nodules | A | M | I | S |
| Peeling | A | M | I | S |
| Depigmentation | A | M | I | S |
| Hyperpigmentation | A | M | I | S |
| Hyperkeratosis (feet) | A | M | I | S |
| Hyperkeratosis and/or Ulcers in nasal region | A | M | I | S |